Cargando…
Protocol for the TIDAL Melanoma Study: topical imiquimod or diphenylcyclopropenone for the management of cutaneous in-transit melanoma metastases—a phase II, single centre, randomised, pilot study
INTRODUCTION: Patients with in-transit melanoma metastases present a therapeutic challenge. Complete surgical excision of localised disease is considered as the gold standard; however, surgery is not always acceptable and alternatives are required. Treatment results reported using imiquimod and diph...
Autores principales: | Read, Tavis, Webber, Scott, Thomas, Janine, Wagels, Michael, Schaider, Helmut, Soyer, H Peter, Smithers, B Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640002/ https://www.ncbi.nlm.nih.gov/pubmed/28988173 http://dx.doi.org/10.1136/bmjopen-2017-016816 |
Ejemplares similares
-
Topical imiquimod in combination with brachytherapy for unresectable cutaneous melanoma scalp metastases
por: Yeh, Jennifer E., et al.
Publicado: (2022) -
Intralesional PV‐10 for the treatment of in‐transit melanoma metastases—Results of a prospective, non‐randomized, single center study
por: Read, Tavis A., et al.
Publicado: (2018) -
Results of a phase II, open‐label, non‐comparative study of intralesional PV‐10 followed by radiotherapy for the treatment of in‐transit or metastatic melanoma
por: Foote, Matthew, et al.
Publicado: (2017) -
Regional vitiligo induced by imiquimod treatment for in-transit melanoma metastases
por: Tkachenko, Elizabeth, et al.
Publicado: (2019) -
Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial
por: Teulings, Hansje-Eva, et al.
Publicado: (2018)